Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

On-Demand Treatment of Bleeding Episodes in Patients with Hereditary Factor X Deficiency Using a High-Purity Factor X Concentrate: Data from 2 Clinical Trials and a Data-Collection Study

James N. Huang, MD, Chioma Akanezi, BSc, PgDip, Amy Shapiro

Blood (2018) 132 (Supplement 1): 1215.

https://doi.org/10.1182/blood-2018-99-111397

Published: 2018

Journal Articles

Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease

Gina Patel, Parameswaran Hari, MD MRCP, MS, Aniko Szabo, PhD, Rein Lisa, Lisa M. Baumann Kreuziger, MD MS, Saurabh Chhabra, MD, Binod Dhakal, MBBS, Anita D'Souza, MBBS

Blood (2017) 130 (Supplement 1): 2363.

https://doi.org/10.1182/blood.V130.Suppl_1.2363.2363

Published: 2017

Journal Articles

Splenectomy in a Severe Case of Acquired Factor X Deficiency Secondary to Amyloidosis: Case Discussion and Review of the Literature

Terrence J Bradley, MD, Matthew P Salzberg, MD, George Nahas, DO, Basem Azab, MD, Alan Livingstone, MD, John J. Byrnes, MD, Thomas J. Harrington, MD, James E. Hoffman, MD

Blood (2017) 130 (Supplement 1): 4885.

https://doi.org/10.1182/blood.V130.Suppl_1.4885.4885

Published: 2017

Journal Articles

Acquired Factor X Deficiency in Systemic Light Chain Amyloidosis: Factor X Recovery after Bleeding Complications, Splenectomy, Chemotherapy and Remission

Rosa Toenges, MD, Juliane Steinmann, MD, Annelie Siegemund, MD, Hubert Serve, Wolfgang A. Miesbach, MD PhD

Blood (2017) 130 (Supplement 1): 4892.

https://doi.org/10.1182/blood.V130.Suppl_1.4892.4892

Published: 2017

Journal Articles

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

James N. Huang, MD, Ri Liesner, Chioma Akenezi, BSc, PgDip, Steven K. Austin, BMedSci, MBBS, Kaan Kavakli, MD

Blood (2017) 130 (Supplement 1): 3736.

https://doi.org/10.1182/blood.V130.Suppl_1.3736.3736

Published: 2017

Journal Articles

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Mahdi Shahriari, MD, Mehran Karimi, MD

Blood (2016) 128 (22): 4801.

https://doi.org/10.1182/blood.V128.22.4801.4801

Published: 2016

Journal Articles

Genotype Analysis of Patients with Hereditary Factor X Deficiency Enrolled in 2 Phase 3 Studies of Pdfx, a New High-Purity Factor X Concentrate

Mike Mitchell, PhD, Kaan Kavakli, MD, Miranda Norton, PhD, Steve Austin

Blood (2015) 126 (23): 3511.

https://doi.org/10.1182/blood.V126.23.3511.3511

Published: 2015

Journal Articles

Importance of Pharmacokinetic Studies in the Management of Acquired Factor X Deficiency

Ming Yeong Lim, MBBChir, Timothy A. McCarthy, MD, Sheh-Li Chen, Pharm D, Alice D Ma, MD

Blood (2014) 124 (21): 5059.

https://doi.org/10.1182/blood.V124.21.5059.5059

Published: 2014

Journal Articles

Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis

Shameem Mahmood, Julie Blundell, Anja Drebes, Philip N. Hawkins, Ashutosh D. Wechalekar

Blood (2014) 123 (18): 2899–2900.

https://doi.org/10.1182/blood-2014-02-556514

Published: 2014

Includes: Supplemental data

Journal Articles

A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis

Anish S. Konde, MB BS, Charles Camposano, Mushtaq Farah, Puppala Mamta, Wong Solomon, George Carrum, McCarthy John, Kelty R. Baker, MD, Jerry Estep, Arvind Bhimraj, Rammurti Kamble, MD, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD, MB, BS

Blood (2013) 122 (21): 3603.

https://doi.org/10.1182/blood.V122.21.3603.3603

Published: 2013

Journal Articles

Concomittant Acquired Von Willebrand Disease and Acquired Factor V Deficiency Causing a Severe Bleeding Diathesis Due To Multiple Myeloma With Amyloidosis

Nataliya Melnyk, MD, Jonathan Harrison, MD

Blood (2013) 122 (21): 4788.

https://doi.org/10.1182/blood.V122.21.4788.4788

Published: 2013

Journal Articles

Rare Congenital Bleeding Disorders from a Tertiary Haematology Referral Center in Western India

Anjali Jaydeep Kelkar, MD, MNAMS, MBBS, Shashikant Apte, MD, FRCPA, Varsha Melinkeri, Samir Melinkeri, Ashay Karpe, Saurabh Bhave, Bhavna Sayaji

Blood (2008) 112 (11): 4519.

https://doi.org/10.1182/blood.V112.11.4519.4519

Published: 2008

Journal Articles

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Carrie Thompson, MD, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, John A. Heit, MD, Rajiv Pruthi, MD, Animesh D. Pardanani, MD

Blood (2007) 110 (11): 3965.

https://doi.org/10.1182/blood.V110.11.3965.3965

Published: 2007

Journal Articles

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Andrea Gerhardt, MD, Fatima Araba, MD, Rainer B. Zotz, MD, Rudiger E. Scharf, MD

Blood (2006) 108 (11): 4050.

https://doi.org/10.1182/blood.V108.11.4050.4050

Published: 2006

Journal Articles

Acquired Factor IX (fIX) Deficiency Associated with a Multiple Myeloma.

Severine Lissandre, MD, Catherine Ternisien, MD, Marie-Christine Rousselet, MD, Aline Tanguy-Schmidt, MD, Norbert Ifrah, MD PhD, Mathilde Hunault-Berger, MD PhD

Blood (2006) 108 (11): 4061.

https://doi.org/10.1182/blood.V108.11.4061.4061

Published: 2006

Journal Articles

Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.

Cynthia A. Kos, MA, Jennifer E. Ward, Karim Malek, MD, Vaishali Sanchorawala, MD, Daniel G. Wright, MD, Carl O’Hara, MD, Lawreen Connors, Ph.D, Martha Skinner, MD, David C. Seldin, MD

Blood (2005) 106 (11): 4078.

https://doi.org/10.1182/blood.V106.11.4078.4078

Published: 2005

Journal Articles

A Multi-Instrument Evaluation of a Commercial Chromogenic Factor X Assay To Monitor Oral Anticoagulation Therapy.

David L. McGlasson, MS, Patrick N. Shaklee, PhD

Blood (2004) 104 (11): 4059.

https://doi.org/10.1182/blood.V104.11.4059.4059

Published: 2004

Journal Articles

Six Novel Mutations Including Triple Heterozygosity for Phe31Ser, 514delT and 516T→G Mutations in Factor X Gene Is Responsible for Congenital Factor X Deficiency in Patients of Indian and Nepali Origin.

G Jayandharan, RV Shaji, Auro Viswabandhya, Sukesh C. Nair, Joy Mammen, Biju George, Vikram Mathews, Mammen Chandy, Alok Srivastava

Blood (2004) 104 (11): 1042.

https://doi.org/10.1182/blood.V104.11.1042.1042

Published: 2004

Journal Articles

Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy

Elie B. Choufani, Vaishali Sanchorawala, Timothy Ernst, Karen Quillen, Martha Skinner, Daniel G. Wright, David C. Seldin

Blood (2001) 97 (6): 1885–1887.

https://doi.org/10.1182/blood.V97.6.1885

Published: 2001

Journal Articles

Therapeutic Levels of Functional Human Factor X in Rats After Retroviral-Mediated Hepatic Gene Therapy

MaiThao Le, Torayuki Okuyama, Shi-Rong Cai, Susan C. Kennedy, William M. Bowling, M. Wayne Flye, Katherine Parker Ponder

Blood (1997) 89 (4): 1254–1259.

https://doi.org/10.1182/blood.V89.4.1254

Published: 1997

NARROW

On-Demand Treatment of Bleeding Episodes in Patients with Hereditary Factor X Deficiency Using a High-Purity Factor X Concentrate: Data from 2 Clinical Trials and a Data-Collection Study

Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease

Splenectomy in a Severe Case of Acquired Factor X Deficiency Secondary to Amyloidosis: Case Discussion and Review of the Literature

Acquired Factor X Deficiency in Systemic Light Chain Amyloidosis: Factor X Recovery after Bleeding Complications, Splenectomy, Chemotherapy and Remission

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Genotype Analysis of Patients with Hereditary Factor X Deficiency Enrolled in 2 Phase 3 Studies of Pdfx, a New High-Purity Factor X Concentrate

Importance of Pharmacokinetic Studies in the Management of Acquired Factor X Deficiency

Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis

A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis

Concomittant Acquired Von Willebrand Disease and Acquired Factor V Deficiency Causing a Severe Bleeding Diathesis Due To Multiple Myeloma With Amyloidosis

Rare Congenital Bleeding Disorders from a Tertiary Haematology Referral Center in Western India

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Acquired Factor IX (fIX) Deficiency Associated with a Multiple Myeloma.

Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.

A Multi-Instrument Evaluation of a Commercial Chromogenic Factor X Assay To Monitor Oral Anticoagulation Therapy.

Six Novel Mutations Including Triple Heterozygosity for Phe31Ser, 514delT and 516T→G Mutations in Factor X Gene Is Responsible for Congenital Factor X Deficiency in Patients of Indian and Nepali Origin.

Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy

Therapeutic Levels of Functional Human Factor X in Rats After Retroviral-Mediated Hepatic Gene Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only